191 related articles for article (PubMed ID: 1929726)
1. [Fetal toxoplasmosis. In utero treatment with pyrimethamine sulfamides].
Couvreur J; Thulliez P; Daffos F; Aufrant C; Bompard Y; Gesquière A; Desmonts G
Arch Fr Pediatr; 1991; 48(6):397-403. PubMed ID: 1929726
[TBL] [Abstract][Full Text] [Related]
2. In utero treatment of toxoplasmic fetopathy with the combination pyrimethamine-sulfadiazine.
Couvreur J; Thulliez P; Daffos F; Aufrant C; Bompard Y; Gesquière A; Desmonts G
Fetal Diagn Ther; 1993; 8(1):45-50. PubMed ID: 8452648
[TBL] [Abstract][Full Text] [Related]
3. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study.
McLeod R; Boyer K; Karrison T; Kasza K; Swisher C; Roizen N; Jalbrzikowski J; Remington J; Heydemann P; Noble AG; Mets M; Holfels E; Withers S; Latkany P; Meier P;
Clin Infect Dis; 2006 May; 42(10):1383-94. PubMed ID: 16619149
[TBL] [Abstract][Full Text] [Related]
4. [Diagnosis and therapy of toxoplasmosis infections in pregnancy at the Rostock University Gynecologic Clinic 1986-1994].
Briese V; Rogmann K; Müller H; Plesse R
Zentralbl Gynakol; 1995; 117(11):578-84. PubMed ID: 8533491
[TBL] [Abstract][Full Text] [Related]
5. Neurologic and developmental outcome in treated congenital toxoplasmosis.
Roizen N; Swisher CN; Stein MA; Hopkins J; Boyer KM; Holfels E; Mets MB; Stein L; Patel D; Meier P
Pediatrics; 1995 Jan; 95(1):11-20. PubMed ID: 7770286
[TBL] [Abstract][Full Text] [Related]
6. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis.
Daffos F; Forestier F; Capella-Pavlovsky M; Thulliez P; Aufrant C; Valenti D; Cox WL
N Engl J Med; 1988 Feb; 318(5):271-5. PubMed ID: 3336419
[TBL] [Abstract][Full Text] [Related]
7. [Strategies for the diagnosis and treatment of prenatal toxoplasmosis - a survey].
Christoph J; Kattner E; Seitz HM; Reiter-Owona I
Z Geburtshilfe Neonatol; 2004 Feb; 208(1):10-6. PubMed ID: 15039886
[TBL] [Abstract][Full Text] [Related]
8. Treatment of congenital toxoplasmosis.
Wilson CB
Pediatr Infect Dis J; 1990 Sep; 9(9):682-3. PubMed ID: 2235199
[No Abstract] [Full Text] [Related]
9. [Prevention of congenital toxoplasmosis].
Russo M; Galanti B
Clin Ter; 1990 Sep; 134(6):383-92. PubMed ID: 2149535
[TBL] [Abstract][Full Text] [Related]
10. [Toxoplasmosis retinochorioiditis, a therapy comparison between spiramycin and pyrimethamine/sulfadiazine].
Hacker M; Richter R; Gümbel H; Richter T; Ohrloff C
Klin Monbl Augenheilkd; 1998 Feb; 212(2):84-7. PubMed ID: 9577806
[TBL] [Abstract][Full Text] [Related]
11. [In utero treatment of congenital toxoplasmosis with a pyrimethamine-sulfadiazine combination].
Couvreur J
Presse Med; 1991 Jun; 20(24):1136. PubMed ID: 1830148
[No Abstract] [Full Text] [Related]
12. Diagnostic problems and postnatal follow-up in congenital toxoplasmosis.
Mazzola A; Casuccio A; Romano A; Schimmenti MG; Titone L; Di Carlo P
Minerva Pediatr; 2007 Jun; 59(3):207-13. PubMed ID: 17519865
[TBL] [Abstract][Full Text] [Related]
13. Neonatal screening for congenital toxoplasmosis in a cohort of 165 women infected during pregnancy and influence of in utero treatment on the results of neonatal tests.
Bessières MH; Berrebi A; Rolland M; Bloom MC; Roques C; Cassaing S; Courjault C; Séguéla JP
Eur J Obstet Gynecol Reprod Biol; 2001 Jan; 94(1):37-45. PubMed ID: 11134824
[TBL] [Abstract][Full Text] [Related]
14. Prenatal therapy with pyrimethamine + sulfadiazine vs spiramycin to reduce placental transmission of toxoplasmosis: a multicenter, randomized trial.
Mandelbrot L; Kieffer F; Sitta R; Laurichesse-Delmas H; Winer N; Mesnard L; Berrebi A; Le Bouar G; Bory JP; Cordier AG; Ville Y; Perrotin F; Jouannic JM; Biquard F; d'Ercole C; Houfflin-Debarge V; Villena I; Thiébaut R;
Am J Obstet Gynecol; 2018 Oct; 219(4):386.e1-386.e9. PubMed ID: 29870736
[TBL] [Abstract][Full Text] [Related]
15. [Use of the ISAGA method in detection of specific IgM, IgA, IgE antibodies in acquired and congenital toxoplasmosis].
Paul M
Wiad Parazytol; 1997; 43(1):39-51. PubMed ID: 9289926
[TBL] [Abstract][Full Text] [Related]
16. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group.
Guerina NG; Hsu HW; Meissner HC; Maguire JH; Lynfield R; Stechenberg B; Abroms I; Pasternack MS; Hoff R; Eaton RB
N Engl J Med; 1994 Jun; 330(26):1858-63. PubMed ID: 7818637
[TBL] [Abstract][Full Text] [Related]
17. [Postnatal follow-up of infants born to mothers with certain Toxoplasma gondii infection: evaluation of prenatal management].
Di Carlo P; Mazzola A; Romano A; Schimmenti MG; Colicchia P; Bellipanni P; Titone L
Infez Med; 2005 Jun; 13(2):72-8. PubMed ID: 16220026
[TBL] [Abstract][Full Text] [Related]
18. [Recommendations for the treatment of prenatal toxoplasma infection in the child. German Society of Pediatric Infectiology e.V. (DGPI), "Parasitology" Study Group].
Döhring-Schwerdtfeger E; Leichsenring M; Liefke U; Padelt H; Sitzmann FC; Stehr K; Zimmermann PH
Klin Padiatr; 1995; 207(1):38-41. PubMed ID: 7885018
[No Abstract] [Full Text] [Related]
19. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
[TBL] [Abstract][Full Text] [Related]
20. [Limitations of prenatal treatment of congenital toxoplasmosis with a sulfadiazine-pyrimethamine combination].
Boulot P; Pratlong F; Sarda P; Deschamps F; Hedon B; Laffargue F; Viala JL
Presse Med; 1990 Mar; 19(12):570. PubMed ID: 2139220
[No Abstract] [Full Text] [Related]
[Next] [New Search]
